Astellas Pharma is focusing on diversification, with its portfolio spanning cancer, vision loss and menopause treatments. Its Chief Medical Officer, Tadaaki Taniguci, said the company was also expanding its gene therapy output, using acquisitions and licensing to build capability, while in oncology, the firm’s lead drugs include treatments for prostate and bladder cancer. Astellas is also testing a small molecule for treating menopause symptoms.
4,300+ Outdated Routers Hijacked in Stealthy Spy Infrastructure by AryStinger malware – Security Affairs
4,300+ Outdated Routers Hijacked in Stealthy Spy Infrastructure by AryStinger malware Security Affairs
.webp?w=0&resize=0,0&ssl=1 "North Korean Hackers Abuse Mastra npm Supply Chain to Target Developers and CI/CD Pipelines")
